Home » Topics » BioWorld Science

BioWorld Science
RSS

ViiV Healthcare discovers new HIV-1 Capsid protein p24 assembly inhibitors

May 14, 2020

Nurix Therapeutics patents Bruton tyrosine kinase-degrading compounds

May 14, 2020

Ascletis receives IND approval in China for clinical development of ASC-41 in NASH

May 14, 2020

Insilico Medicine Hong Kong discovers DDR1 inhibitors

May 14, 2020

Enrollment of first patient in phase III study of viltolarsen in boys with DMD

May 14, 2020

New androgen receptor antagonists described by ESSA Pharma

May 14, 2020

Sunovion discontinues development of dasotraline

May 14, 2020

First patient dosed in phase I/II study of TJD5 in China

May 14, 2020

Discovery of potent BACE1 inhibitor, AM-6494

May 14, 2020

TBR-760 results in complete arrested tumor growth in mouse model of NFPA

May 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...